Lantero Rodriguez J, Karikari TK, Suárez-Calvet M, Troakes C, King A, Emersic A, Aarsland D, Hye A, Zetterberg H, Blennow K, Ashton NJ. Plasma p-tau181 accurately predicts Alzheimer's disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline. Acta Neuropathol. 2020 Sep;140(3):267-278. Epub 2020 Jul 27 PubMed.
AlzBiomarker Database
Meta-Analysis
Curated Study Data
| Biomarker (Source) |
Cohort (N) |
Measurement Mean ± SD |
Method; Assay Name; Manufacturer |
Diagnostic Criteria |
|---|---|---|---|---|
| tau-p181 (Plasma) |
AD (77) |
28.4 ± 9.6 pg/mL |
SIMOA; Other/Not Specified; In-house |
1993 |
| tau-p181 (Plasma) |
CTRL- CNC (28) |
19.3 ± 9.9 pg/mL |
SIMOA; Other/Not Specified; In-house |
Recommends
Please login to recommend the paper.
Comments
No Available Comments
Make a Comment
To make a comment you must login or register.